Advertisement

Table of Contents

September 10, 2019; 3 (17)

BLOOD ADVANCES TALK

EXCEPTIONAL CASE REPORTS

STIMULUS REPORT

  • Sphingolipid metabolism determines the therapeutic efficacy of nanoliposomal ceramide in acute myeloid leukemia
    Brian M. Barth, Weiyuan Wang, Paul T. Toran, Todd E. Fox, Charyguly Annageldiyev, Regina M. Ondrasik, Nicole R. Keasey, Timothy J. Brown, Viola G. Devine, Emily C. Sullivan, Andrea L. Cote, Vasiliki Papakotsi, Su-Fern Tan, Sriram S. Shanmugavelandy, Tye G. Deering, David B. Needle, Stephan T. Stern, Junjia Zhu, Jason Liao, Aaron D. Viny, David J. Feith, Ross L. Levine, Hong-Gang Wang, Thomas P. Loughran Jr, Arati Sharma, Mark Kester and David F. Claxton

REVIEW ARTICLE

SYSTEMATIC REVIEW

GENE THERAPY

LYMPHOID NEOPLASIA

PLATELETS AND THROMBOPOIESIS

RED CELLS, IRON, AND ERYTHROPOIESIS

TRANSPLANTATION

  • Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1
    Increased overall and bacterial infections following myeloablative allogeneic HCT for patients with AML in CR1
    Celalettin Ustun, Soyoung Kim, Min Chen, Amer M. Beitinjaneh, Valerie I. Brown, Parastoo B. Dahi, Andrew Daly, Miguel Angel Diaz, Cesar O. Freytes, Siddhartha Ganguly, Shahrukh Hashmi, Gerhard C. Hildebrandt, Hillard M. Lazarus, Taiga Nishihori, Richard F. Olsson, Kristin M. Page, Genovefa Papanicolaou, Ayman Saad, Sachiko Seo, Basem M. William, John R. Wingard, Baldeep Wirk, Jean A. Yared, Miguel-Angel Perales, Jeffery J. Auletta, Krishna V. Komanduri, Caroline A. Lindemans and Marcie L. Riches
  • Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children
    Dose-escalated interleukin-2 therapy for refractory chronic graft-versus-host disease in adults and children
    Jennifer S. Whangbo, Haesook T. Kim, Nikola Mirkovic, Lauren Leonard, Samuel Poryanda, Sophie Silverstein, Soomin Kim, Carol G. Reynolds, Sharmila C. Rai, Kelly Verrill, Michelle A. Lee, Steven Margossian, Christine Duncan, Leslie Lehmann, Jennifer Huang, Sarah Nikiforow, Edwin P. Alyea III, Philippe Armand, Corey S. Cutler, Vincent T. Ho, Bruce R. Blazar, Joseph H. Antin, Robert J. Soiffer, Jerome Ritz and John Koreth
  • Related and unrelated donor transplantation for β-thalassemia major: results of an international survey
    Related and unrelated donor transplantation for β-thalassemia major: results of an international survey
    Chunfu Li, Vikram Mathews, Soyoung Kim, Biju George, Kyle Hebert, Hua Jiang, Changgang Li, Yiping Zhu, Daniel A. Keesler, Jaap Jan Boelens, Christopher C. Dvorak, Rajni Agarwal, Jeffery J. Auletta, Rakesh K. Goyal, Rabi Hanna, Kimberly Kasow, Shalini Shenoy, Angela R. Smith, Mark C. Walters and Mary Eapen
  • “Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients
    “Mini” bank of only 8 donors supplies CMV-directed T cells to diverse recipients
    Ifigeneia Tzannou, Ayumi Watanabe, Swati Naik, Rachel Daum, Manik Kuvalekar, Kathryn S. Leung, Caridad Martinez, Ghadir Sasa, Mengfen Wu, Adrian P. Gee, Robert A. Krance, Stephen Gottschalk, Helen E. Heslop and Bilal Omer
  • Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70
    Haploidentical transplantation using posttransplant cyclophosphamide as GVHD prophylaxis in patients over age 70
    Philip H. Imus, Hua-Ling Tsai, Leo Luznik, Ephraim J. Fuchs, Carol Ann Huff, Douglas E. Gladstone, Patrick Lowery, Richard F. Ambinder, Ivan M. Borrello, Lode J. Swinnen, Nina Wagner-Johnston, Christian B. Gocke, Syed Abbas Ali, F. Javier Bolaños-Meade, Ravi Varadhan and Richard J. Jones

COMMENTARY